ReviewFrontiers in cellular and infection microbiology2026
Microbiotherapy: an emerging adjunct for burn wound healing.
Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Burn injuries rank among the most common types of severe trauma, typically causing damage to skin tissue. However, traditional management strategies, particularly those relying on broad-spectrum antibiotics, face the dual challenges of increased drug resistance and limited wound healing efficacy, necessitating urgent development of novel therapeutic strategies. In recent years, microbiotherapy has garnered significant attention as a potential adjuvant therapy in burn wound management. Microbiotherapy achieves antibacterial effects by competitively inhibiting pathogen adhesion and secreting metabolites. Additionally, it promotes burn wound healing through the secretion of anti-inflammatory and growth factors, as well as the restoration of immune homeostasis. This approach aligns with the field's shift toward personalized therapy, where microbial interventions can be tailored to the specific microenvironment of a patient's wound. Current microbiotherapies for burn treatment primarily focus on probiotics, bacteriophages, and microbial metabolic derivatives. These therapies can be used individually or in combination and are gradually transitioning from laboratory early-stage research to clinical application. Probiotics, the core component of microbiotherapy, exert their therapeutic effects mainly by secreting various metabolites. This review summarizes the latest advances in microbiotherapy for burn wound treatment, focusing on its mechanisms of action,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.